SMi is proud to announce the return the 12th annual Asthma & COPD conference 2016 in London!
Respiratory diseases represent an enormous and increasing healthcare and economic burden across Europe and USA. Over the last few years, significant improvements in the management of asthma and COPD have been made, owing to new drugs, strategies and to the development of the nonpharmacologic treatment of COPD. Nevertheless, there are still many unmet needs in the treatment of these diseases.
Join us at SMi's 12th annual Asthma & COPD taking place on the 11th - 12th April 2016 in London. This event will explore innovative asthma and COPD drug development programmes, directives and procedures which have been put in place to reduce the enormous suffering from lung disease and its high mortality.
A series of practical case studies, interactive roundtables and panel discussion facilitated by leading industry experts will provide executives with useful tools and best practices to: develop vaccination approaches for asthma improve inhaled therapies in COPD and development of antivirals evaluate the impact of COPD phenotypes on therapy explore biomarkers for respiratory drug assessment learn about stratified medicine and prevent exacerbation in asthma and COPD
and many more...
Electronic Access - Single User Fulfilled By Publisher
Electronic Access - Global site License Fulfilled By Publisher